The first essay studies how the change in payment mechanism shifts hospital investment from quality-enhancing technologies to cost-saving technologies. A by-product of this change is more potential for for-profit hospitals to capture a larger share of the market. With a retrospective average cost-based program, the not-for-profit hospital invests only in the qualityenhancing technology. The for-profit hospital has no incentive to invest in either technology. When hospitals are reimbursed prospectively, however, the not-for-profit hospital invests in both the quality improving and the cost saving technologies, as does the for-profit hospital, although at lesser amounts, and market shares are more equal. The results of these analysis help exp...